Mediators of Inflammation

Macrophage-Mediated Inflammatory Disorders


Publishing date
01 Feb 2013
Status
Published
Submission deadline
14 Sep 2012

Lead Editor

1Department of Orthopedics, College of Medicine, National Cheng Kung University, 138 Sheng-Li Road, Tainan 704, Taiwan

2Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, 138 Sheng-Li Road, Tainan 704, Taiwan

3Department of Pharmacology, The University of Texas Health Science Center, San Antonio, TX 78229-3900, USA


Macrophage-Mediated Inflammatory Disorders

Description

Mediators of macrophage-induced inflammation are critical for a variety of human inflammatory disorders, such as sepsis-related multiple organ dysfunction/multiple organ failure, microbial infection, acute brain, lung, hepatic, renal injuries, neurodegenerative disorders, tumorigenesis, osteoporosis/osteonecrosis, cardiovascular and metabolic diseases, and autoimmune diseases. Most of these cases are proinflammatory and pathogenic for disease progression once the activated macrophages actively secrete and cause an imbalance of cytokines, chemokines, and inflammation mediators. For inflammation resolution, anti-inflammatory cytokines such as interleukin-10 and transforming growth factor-β are also regulated for macrophage activation to repair the inflammatory insults. In addition to secreting mediators of inflammation, macrophage-mediated phagocytosis is generally involved not only for inflammation but also anti-inflammation.

The primary focus of this special issue will be on the current and updated knowledge of macrophage-mediated inflammatory disorders, particularly on the pathogenesis of the macrophage activation, mediators of inflammation and anti-inflammation, and strategies against such effects. In this special issue, both reviews and original research articles are welcomed. Moreover, papers showing novel methods for detecting macrophage activation and differentiation would be of great interest. Potential topics include, but are not limited to:

  • Macrophages in infection and immunity
  • Macrophages in acute brain, lung, hepatic, renal injuries, and autoimmunity
  • Macrophage/microglia in neurodegenerative disorders
  • Tumor-associated macrophages in tumorigenesis
  • Macrophages in inflammatory/autoimmune musculoskeletal diseases
  • Macrophages in cardiovascular disorders and metabolic diseases

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/mi/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:

Mediators of Inflammation
 Journal metrics
See full report
Acceptance rate14%
Submission to final decision136 days
Acceptance to publication27 days
CiteScore7.700
Journal Citation Indicator0.570
Impact Factor4.6
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.